BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26267418)

  • 1. Antidepressants in Type II Versus Type I Bipolar Depression: A Randomized Discontinuation Trial.
    Vöhringer PA; Ostacher MJ; El-Mallakh RS; Holtzman NS; Thommi SB; Whitham EA; Sullivan MC; Baldassano CF; Goodwin FK; Baldessarini RJ; Ghaemi SN
    J Clin Psychopharmacol; 2015 Oct; 35(5):605-8. PubMed ID: 26267418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
    Ghaemi SN; Ostacher MM; El-Mallakh RS; Borrelli D; Baldassano CF; Kelley ME; Filkowski MM; Hennen J; Sachs GS; Goodwin FK; Baldessarini RJ
    J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.
    Post RM; Leverich GS; Nolen WA; Kupka RW; Altshuler LL; Frye MA; Suppes T; McElroy S; Keck P; Grunze H; Walden J;
    Bipolar Disord; 2003 Dec; 5(6):396-406. PubMed ID: 14636363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing patterns of antidepressants, antipsychotics and mood stabilizers in bipolar patients misdiagnosed with major depressive disorder in China.
    Xiang YT; Hu C; Wang G; Zheng QW; Fang YR; Ungvari GS; Kilbourne AM; Lai KY; Si TM; Chen DF; Lu Z; Yang HC; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
    Hum Psychopharmacol; 2012 Nov; 27(6):626-31. PubMed ID: 23027671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.
    Altshuler L; Suppes T; Black D; Nolen WA; Keck PE; Frye MA; McElroy S; Kupka R; Grunze H; Walden J; Leverich G; Denicoff K; Luckenbaugh D; Post R
    Am J Psychiatry; 2003 Jul; 160(7):1252-62. PubMed ID: 12832239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial.
    El-Mallakh RS; Vöhringer PA; Ostacher MM; Baldassano CF; Holtzman NS; Whitham EA; Thommi SB; Goodwin FK; Ghaemi SN
    J Affect Disord; 2015 Sep; 184():318-21. PubMed ID: 26142612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials.
    Liu B; Zhang Y; Fang H; Liu J; Liu T; Li L
    J Affect Disord; 2017 Dec; 223():41-48. PubMed ID: 28715727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status and management of patients with bipolar disorder in France: the MONTRA survey].
    Llorca PM; Camus V; Courtet P; Gourion D; Lukasiewicz M; Coulomb S
    Encephale; 2013 Jun; 39(3):212-23. PubMed ID: 23726753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
    Perlis RH; Ostacher MJ; Patel JK; Marangell LB; Zhang H; Wisniewski SR; Ketter TA; Miklowitz DJ; Otto MW; Gyulai L; Reilly-Harrington NA; Nierenberg AA; Sachs GS; Thase ME
    Am J Psychiatry; 2006 Feb; 163(2):217-24. PubMed ID: 16449474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and therapeutic implications of predominant polarity in bipolar disorder.
    Colom F; Vieta E; Daban C; Pacchiarotti I; Sánchez-Moreno J
    J Affect Disord; 2006 Jul; 93(1-3):13-7. PubMed ID: 16650901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
    Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
    J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agitated depression in bipolar II disorder.
    Benazzi F
    World J Biol Psychiatry; 2005; 6(3):198-205. PubMed ID: 16166029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of treatment latency on response to maintenance treatment in manic-depressive disorders.
    Baldessarini RJ; Tondo L; Baethge CJ; Lepri B; Bratti IM
    Bipolar Disord; 2007 Jun; 9(4):386-93. PubMed ID: 17547585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Course and outcome after the first manic episode in patients with bipolar disorder: prospective 12-month data from the Systematic Treatment Optimization Program For Early Mania project.
    Yatham LN; Kauer-Sant'Anna M; Bond DJ; Lam RW; Torres I
    Can J Psychiatry; 2009 Feb; 54(2):105-12. PubMed ID: 19254441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential outcome of bipolar patients receiving antidepressant monotherapy versus combination with an antimanic drug.
    Pacchiarotti I; Valentí M; Colom F; Rosa AR; Nivoli AM; Murru A; Sánchez-Moreno J; Vieta E
    J Affect Disord; 2011 Mar; 129(1-3):321-6. PubMed ID: 20817267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a relationship between depression with anxious distress DSM-5 specifier and bipolarity? A multicenter cohort study on patients with unipolar, bipolar I and II disorders.
    Tundo A; Musetti L; de Filippis R; Grande CD; Falaschi V; Proietti L; Dell'Osso L
    J Affect Disord; 2019 Feb; 245():819-826. PubMed ID: 30699865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term treatment of depressive illnesses].
    Deisenhammer EA; Hinterhuber H
    Wien Med Wochenschr; 1999; 149(18):515-9. PubMed ID: 10637956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in outcome of DSM-IV bipolar I and II disorders.
    Mantere O; Suominen K; Valtonen HM; Arvilommi P; Leppämäki S; Melartin T; Isometsä E
    Bipolar Disord; 2008 May; 10(3):413-25. PubMed ID: 18402629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.
    Goldberg JF; Perlis RH; Ghaemi SN; Calabrese JR; Bowden CL; Wisniewski S; Miklowitz DJ; Sachs GS; Thase ME
    Am J Psychiatry; 2007 Sep; 164(9):1348-55. PubMed ID: 17728419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.